R&D

First DataBank's FIRSTLight Goes Live

First DataBank's new online medicines reference tool, FIRSTLight, is now live and First DataBank is offering a free extended trial until the end of January 2011. FIRSTLight provides instant access to reliable medicines information, empowering clinicians and supporting safer, faster clinical decision making.

Study highlights smoking-rheumatoid arthritis link

Smoking may be responsible for over a third of cases of the commonest and most severe form of rheumatoid arthritis (RA), new EU-funded research suggests. Furthermore, in people with a greater genetic susceptibility to RA, smoking may be behind over half of all cases. The findings, published in the journal the Annals of the Rheumatic Diseases, provide another reason for health workers to advise people against smoking, particularly for those with a family history of RA.

Government Initiatives will Unlock Enormous Potential Opportunities for the Russian Pharmaceutical Market

With total revenues of $15.3 billion in 2009, the Russian pharmaceutical market is one of the largest in the world. The market is anticipated to remain on a path of dynamic growth from 2010 to 2016 mainly due to multiple initiatives of the Russian Government. However, in the short term, the process of implementing legislative changes could slightly restrain the market's development.

Nutrition deemed a growing challenge for health in the EU and beyond

Over half the EU adult population is now overweight or obese according to the "Health at a Glance: Europe 2010" report published by the European Commission and the OECD. The rate of obesity has more than doubled over the past 20 years in most EU Member States. This has considerable implications on health, health systems and on the wider economy. This is one of the many findings in a report which provides useful insight into the current situation of health in the EU.

New technique to speed up drug development

Scientists working at the European Molecular Biology Laboratory (EMBL) in Grenoble, France have developed a new technique that enables them to introduce up to 15 fluorescent markers to a mammalian cell in one go. They say their findings could help speed up drug development and screening.

Reasons Why mHealth Apps Matters for Pharma

The potential of mHealth solutions has been discussed for many years, but only recently, with the advent of the new smartphone application based mHealth model, have pharmaceutical companies begun to realize how mobile services might be instrumental in the development of exciting innovations in their own businesses.

Europeans are Interested in Online Patient Education Programs

Half of Europeans using the Internet for health information are interested in online patient education programs from pharmaceutical companies, although just a small fraction are currently using these types of programs, according to Manhattan Research's Cybercitizen Health® Europe v10.0 research. The survey explored the digital media and online health behaviors of 3,000 online adults in France, Germany, Italy, Spain, and the United Kingdom.

Research & Development

First DataBank's FIRSTLight Goes Live

Study highlights smoking-rheumatoid arthritis link

Government Initiatives will Unlock Enormous Potential Opportunities for the Russian Pharmaceutical Market

Nutrition deemed a growing challenge for health in the EU and beyond

New technique to speed up drug development

Reasons Why mHealth Apps Matters for Pharma

Europeans are Interested in Online Patient Education Programs

More Pharma News ...